Microglial activation and increased synthesis of complement component C1q precedes blood-brain barrier dysfunction in rats

Molecular Immunology

Volumn 40, Issue 10, 2004, Pages 709-716

  Lynch, Nicholas J ^a   Willis, Colin L ^b   Nolan, Christopher C ^b   Roscher, Silke ^a   Fowler, Maxine J ^b   Weihe, Eberhard ^c   Ray, David E ^b   Schwaeble, Wilhelm J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

3 Chloropropanediol; Blood brain barrier; Complement; Microglia; s Chlorohydrin

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; INTERLEUKIN 1; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BLOOD BRAIN BARRIER; CELL ACTIVATION; CONTROLLED STUDY; IMMUNOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MICROGLIA; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0344413470     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2003.08.009     Document Type: Article

References (39)

1. Bobak D.A., Gaither T.A., Frank M.M., Tenner A.J. Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages. J. Immunol. 138:1987;1150-1156.
2. Bordin S., Ghebrehiwet B., Page R.C. Participation of C1q and its receptor in adherence of human diploid fibroblast. J. Immunol. 145:1990;2520-2526.
3. Botto M., Dell'Agnola C., Bygrave A.E., Thompson E.M., Cook H.T., Petry F., Loos M., Pandolfi P.P., Walport M.J. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19:1998;56-59.
4. Cavanagh J.B., Nolan C.C. The neurotoxicity of alpha-chlorohydrin in rats and mice. II. Lesion topography and factors in selective vulnerability in acute energy deprivation syndromes. Neuropathol. Appl. Neurobiol. 19:1993;471-479.
5. Cavanagh J.B., Nolan C.C., Seville M.P. The neurotoxicity of alpha-chlorohydrin in rats and mice. I. Evolution of the cellular changes. Neuropathol. Appl. Neurobiol. 19:1993;240-252.
6. Dallasta L.M., Pisarov L.A., Esplen J.E., Werley J.V., Moses A.V., Nelson J.A., Achim C.L. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155:1999;1915-1927.
7. Davoust N., Nataf S., Reiman R., Holers M.V., Campbell I.L., Barnum S.R. Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis. J. Immunol. 163:1999;6551-6556.
8. Dietzschold B., Schwaeble W., Schäfer M.K., Hooper D.C., Zehng Y.M., Petry F., Sheng H., Fink T., Loos M., Koprowski H., Weihe E. Expression of C1q, a subcomponent of the rat complement system, is dramatically enhanced in brains of rats with either Borna disease or experimental allergic encephalomyelitis. J. Neurol. Sci. 130:1995;11-16.
9. Goldsmith S.K., Wals P., Rozovsky I., Morgan T.E., Finch C.E. Kainic acid and decorticating lesions stimulate the synthesis of C1q protein in adult rat brain. J. Neurochem. 68:1997;2046-2052.
10. Huang J., Kim L.J., Mealey R., Marsh H.C. Jr., Zhang Y., Tenner A.J., Connolly E.S. Jr., Pinsky D.J. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science. 285:1999;595-599.
11. Huber J.D., Egleton R.D., Davis T.P. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 24:2001;719-725.
12. Jensen M.B., Finsen B., Zimmer J. Morphological and immunophenotypic microglial changes in the denervated fascia dentata of adult rats: correlation with blood-brain barrier damage and astroglial reactions. Exp. Neurol. 143:1997;103-116.
13. Johnson S.A., Pasinetti G.M., Finch C.E. Expression of complement C1qB and C4 mRNAs during rat brain development. Brain Res. Dev. Brain Res. 80:1994;163-174.
14. Kaul M., Loos M. Expression of membrane C1q in human monocyte-derived macrophages is developmentally regulated and enhanced by interferon-gamma. FEBS Lett. 500:2001;91-98.
15. Khachigian L.M., Lindner V., Williams A.J., Collins T. Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science. 271:1996;1427-1431.
16. Lindsberg P.J., Ohman J., Lehto T., Karjalainen-Lindsberg M.L., Paetau A., Wuorimaa T., Carpen O., Kaste M., Meri S. Complement activation in the central nervous system following blood-brain barrier damage in man. Ann. Neurol. 40:1996;587-596.
17. Loihl A.K., Whalen S., Campbell I.L., Mudgett J.S., Murphy S. Transcriptional activation following cerebral ischemia in mice of a promoter-deleted nitric oxide synthase-2 gene. J. Biol. Chem. 274:1999;8844-8849.
18. Lynch N.J., Schneider H., Sim R.B., Bickel U., Schwaeble W.J. In vivo pharmacokinetics of calreticulin S-domain, an inhibitor of the classical complement pathway. Int. Immunopharmacol. 2:2002;415-422.
19. Mead R.J., Singhrao S.K., Neal J.W., Lassmann H., Morgan B.P. The membrane attack complex of complement causes severe demyelination associated with acute axonal injury. J. Immunol. 168:2002;458-465.
20. Melton D.A., Krieg P.A., Rebagliati M.R., Maniatis T., Zinn K., Green M.R. Efficient in vitro synthesis of biologically active RNA and RNA hybridisation probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12:1984;7035-7056.
21. Morgan B.P., Gasque P. Expression of complement in the brain: role in health and disease. Immunol. Today. 17:1996;461-466.
22. Morgan T.E., Rozovsky I., Sarkar D.K., Young-Chan C.S., Nichols N.R., Laping N.J., Finch C.E. Transforming growth factor-beta1 induces transforming growth factor-beta1 and transforming growth factor-beta receptor messenger RNAs and reduces complement C1qB messenger RNA in rat brain microglia. Neuroscience. 101:2000;313-321.
23. Pasinetti G.M., Johnson S.A., Rozovsky I., Lampert-Etchells M., Morgan D.G., Gordon M.N., Morgan T.E., Willoughby D., Finch C.E. Complement C1qB and C4 mRNAs responses to lesioning in rat brain. Exp. Neurol. 118:1992;117-125.
24. Ririe K.M., Rasmussen R.P., Wittwer C.T. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal. Biochem. 245:1997;154-160.
25. Schäfer, M.K., Herman, J.P., Watson, S.J., 1992. In situ hybridisation immunohistochemistry. In: London, E.D. (Ed.). Imaging Drug Action in the Brain. CRC press, Boca Raton, FL, pp. 337-352.
26. Schäfer M.K., Schwaeble W.J., Post C., Salvati P., Calabresi M., Sim R.B., Petry F., Loos M., Weihe E. Complement C1q is dramatically up-regulated in brain microglia in response to transient global cerebral ischemia. J. Immunol. 164:2000;5446-5452.
27. Schwab C., Steele J.C., McGeer P.L. Neurofibrillary tangles of Guam Parkinson-dementia are associated with reactive microglia and complement proteins. Brain Res. 707:1996;196-205.
28. Schwaeble W., Schäfer M.K., Petry F., Fink T., Knebel D., Weihe E., Loos M. Follicular dendritic cells, interdigitating cells, and cells of the monocyte-macrophage lineage are the C1q-producing sources in the spleen. Identification of specific cell types by in situ hybridisation and immunohistochemical analysis. J. Immunol. 155:1995;4971-4978.
29. Singhrao S.K., Neal J.W., Morgan B.P., Gasque P. Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease. Exp. Neurol. 159:1999;362-376.
30. Speth C., Stockl G., Mohsenipour I., Wurzner R., Stoiber H., Lass-Florl C., Dierich M.P. Human immunodeficiency virus type 1 induces expression of complement factors in human astrocytes. J. Virol. 75:2001;2604-2615.
31. Speth C., Dierich M.P., Gasque P. Neuroinvasion by pathogens: a key role of the complement system. Mol. Immunol. 38:2002;669-679.
32. Tenner A.J. Membrane receptors for soluble defense collagens. Curr. Opin. Immunol. 11:1999;34-41.
33. van Beek J., Chan P., Bernaudin M., Petit E., MacKenzie E.T., Fontaine M. Glial responses, clusterin, and complement in permanent focal cerebral ischemia in the mouse. Glia. 31:2000;39-50.
34. van den Berg R.H., Faber-Krol M.C., Sim R.B., Daha M.R. The first subcomponent of complement, C1q, triggers the production of IL-8, IL-6, and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells. J. Immunol. 161:1998;6924-6930.
35. Webster S.D., Galvan M.D., Ferran E., Garzon-Rodriguez W., Glabe C.G., Tenner A.J. Antibody-mediated phagocytosis of the amyloid beta-peptide in microglia is differentially modulated by C1q. J. Immunol. 166:2001;7496-7503.
36. Willis, C.L., Nolan, C.C., Reith, S.N., Lister, T., Guerin, C.J., Mavroudis, G., Prior, M.J.W., Ray, D.E., 2003. A novel non-invasive method for inducing microvascular damage in the rat brain, Glia, in press.
37. Wittwer C.T., Herrmann M.G., Moss A.A., Rasmussen R.P. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques. 22:1997;130-138.
38. Yan S.F., Fujita T., Lu J., Okada K., Shan Zou Y., Mackman N., Pinsky D.J., Stern D.M. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat. Med. 6:2000;1355-1361.
39. Yasojima K., Schwab C., McGeer E.G., McGeer P.L. Up-regulated production and activation of the complement system in Alzheimer's disease brain. Am. J. Pathol. 154:1999;927-936.